Cumberland's Caldolor Injection Receives Permanent J-Code With Reimbursement

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), today announced an important update regarding its Caldolor® (ibuprofen) Injection. The product's permanent J-code, J1741, is now officially associated with a reimbursement price, providing healthcare providers with a CMS-covered, non-opioid option for managing pain and fever.

As the nation continues to face an opioid crisis, non-opioid alternatives, like Caldolor, play a critical role in reducing reliance on opioid medications, supporting safer pain management strategies for patients. With the reimbursement price now linked to J1741, providers can access a CMS-covered, non-opioid pain management option and align treatment strategies with opioid-sparing initiatives.

Caldolor J-Code Details:

• Product: Caldolor® (ibuprofen) Injection
• J-Code: J1741 – Injection, ibuprofen, 100 mg
• Status: Now associated with reimbursement price